Sibel Erdem

Dr. Sibel Erdem serves as Associate Professor in the Department of Medical Biochemistry at Istanbul Medipol University's International School of Medicine. Her academic foundation includes a B.S. in Chemical Education from Marmara University and a Ph.D. in Bioorganic/Biochemistry from Louisiana State University, followed by postdoctoral training at Harvard Medical School and Massachusetts General Hospital.

Educational background:

• B.S. in Chemical Education, Marmara University
• Ph.D. in Bioorganic/Biochemistry, Louisiana State University

Her research centers on targeted nanoparticle drug delivery systems for photodynamic cancer therapy, biomarker-based fluorescent probes for disease detection/treatment, and light-activated medical molecules. Current work focuses on EGFR-targeted theranostics and antibiotic resistance diagnostics.

Publication trends (2014-2025) reveal dominant nanotechnology applications in cancer theranostics, particularly light/pH-responsive nanoparticles for tumor visualization/destruction. Significant secondary contributions include fluorescent beta-lactamase assays for antibiotic resistance and molecular imaging for cardiovascular diseases.

No scientific awards were documented in source materials.

No student advisement or grant information was provided.

Dr. Erdem leads research at Medipol's Research Institute for Health Science and Technologies (SABITA), previously collaborating with Harvard's Center for Systems Biology and Wellman Center for Photomedicine.